Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Refine search results

Preferences help
enabled [disable] Abstract
Number of results

Results found: 2

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  oxime
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
A novel aminoketooxime ligand and its mononuclear Cu(II) and Mn(II) complexes were synthesized. The structures of the synthesized compounds were illuminated by elemental analysis, inductively coupled plasma optical emission spectrometry, the Fourier transform infrared, ¹H- and ¹³C-NMR, UV-Vis, magnetic susceptibility and conductivity measurements. According to the characterization studies ligand to metal ratio was found to be 2:1 with strong binding affinity of the ligand to the metal ions. In addition, complexes have been tested for their catecholase and phenoxazinone synthase-like activities. Kinetic studies were also carried out yielding V_{max}, k_{cat} and K_{M} values of both complexes for catecholase and phenoxazinone synthase-like activities. Both complexes efficiently catalyzed the reactions of the enzymes they mimicked.
EN
A novel ligand, N,N"-(4-methyl-1,2-phenylene)bis(2-(biphenyl-4-yl)-N'-hydroxy-2-oxoacetimidamide) (H₂L) with its Cu(II) and Mn(II) complexes were synthesized in this study. All compounds synthesized were also characterized by ¹H- and ¹³C-NMR, the Fourier transform infrared, elemental analysis, inductively coupled plasma optical emission spectrometry, molar conductivity, magnetic susceptibility measurements and thermogravimetric analysis. Vascular endothelial growth factor-2 (VEGFR-2) and cyclooxygenase-2 (COX-2) inhibition is often used as a parameter for being a potent anticancer agent in docking studies. For this purpose, synthesized and characterized ligand was investigated by molecular docking study to test its inhibitory effect against angiogenic factors VEGFR-2 and COX-2.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.